ọgwụgwọ neuroendocrine akpa ume cancer ọgwụgwọ

Ọgwụgwọ maka Neuroendocrine Lung Cancer

Ọrịa cancer akpa ume Neuroendocrine bụ ụdị ọrịa cancer akpa ume dị ụkọ nke na-esite na mkpụrụ ndụ neuroendocrine nke ngụgụ. Ntuziaka a zuru oke na-enyocha nhọrọ ọgwụgwọ dị iche iche maka ọgwụgwọ ọrịa cancer akpa ume neuroendocrine, na-ekwusi ike mkpa nlekọta ahaziri onwe ya na ọganihu ọhụrụ na ngalaba. Ịghọta nkọwa nke nchoputa gị na iso onye na-ahụ maka oncologist gị na-arụkọ ọrụ dị oke mkpa maka ịmepụta atụmatụ ọgwụgwọ dị irè.

Ịghọta Neuroendocrine Lung Cancer

Ụdị Neuroendocrine Lung Cancer

A na-ekewa ọrịa cancer akpa ume Neuroendocrine n'ime ụdị dị iche iche dabere na njirimara sel ha na usoro uto ha. Ndị a na-agụnye carcinoids ndị a na-ahụkarị, carcinoids atypical, nnukwu cell neuroendocrine carcinomas, na obere ọrịa cancer akpa ume (SCLC). Ụdị nke neuroendocrine akpa ume cancer na-emetụta nke ọma ụzọ ọgwụgwọ.

Ọrịa cancer akpa ume Neuroendocrine

Nhazi na-agụnye ikpebi ókè ọrịa kansa na-agbasa. A na-emekarị nke a site na nyocha onyonyo (CT scans, nyocha PET) ma nwee ike ịgụnye biopsy. Nhazi dị oke mkpa maka ịhọrọ nke kwesịrị ekwesị ọgwụgwọ maka neuroendocrine akpa ume cancer na amụma prognosis.

Nhọrọ ọgwụgwọ maka Neuroendocrine Lung Cancer

Ịwa ahụ

Ịwa ahụ na-abụkarị ọgwụgwọ mbụ maka mmalite mmalite neuroendocrine akpa ume cancer, karịsịa maka etuto ahụ nwere mpaghara. Ụdị ịwa ahụ na-adabere na ebe na nha etuto ahụ. A na-ahọrọkarị usoro mkpasu iwe kacha nta mgbe enwere ike.

Chemotherapy

Chemotherapy na-eji ọgwụ gbuo mkpụrụ ndụ kansa. Enwere ike iji ya naanị ya ma ọ bụ jikọtara ya na ọgwụgwọ ndị ọzọ. Usoro ọgwụgwọ chemotherapy a kapịrị ọnụ na-adabere n'ụdị na ogbo nke neuroendocrine akpa ume cancer. Ndị ọrụ chemotherapeutic a na-ejikarị gụnyere carboplatin na etoposide maka SCLC.

Usoro ọgwụgwọ radieshon

Usoro ọgwụgwọ radieshon na-eji radieshon ike dị elu mebie mkpụrụ ndụ kansa. Enwere ike iji ya belata etuto ahụ, belata mgbaàmà, ma ọ bụ gbochie nlọghachi ọrịa kansa. A na-ejikarị ọgwụgwọ radieshon na-apụ apụ, mana brachytherapy (ụzarị dị n'ime) nwekwara ike ịbụ nhọrọ.

Usoro ọgwụgwọ ezubere iche

Usoro ọgwụgwọ ezubere iche na-eji ọgwụ na-elekwasị anya kpọmkwem ụmụ irighiri ihe na-etinye aka na uto cell na nlanarị. Usoro ọgwụgwọ ndị a na-adịkarị irè ma nwee mmetụta dị ole na ole karịa chemotherapy ọdịnala. Nnweta ọgwụgwọ ezubere iche maka ọgwụgwọ ọrịa cancer akpa ume neuroendocrine dabere n'ụdị kpọmkwem na profaịlụ mkpụrụ ndụ ihe nketa nke etuto ahụ. Ọmụmatụ gụnyere ihe mgbochi na-ezubere iche nke tyrosine kinases nnabata.

Immunotherapy

Immunotherapy na-eji ike nke sistemu ahụ ji alụso ọrịa ọgụ ọgụ. Ọ na-arụ ọrụ site n'ịkwalite usoro ahụ ji alụso ọrịa ọgụ ịmata na ịwakpo mkpụrụ ndụ kansa. Ndị na-egbochi ihe mgbochi mgbochi mgbochi, dị ka pembrolizumab na atezolizumab, egosila nkwa n'ịgwọ ụdị ụfọdụ. neuroendocrine akpa ume cancer.

Ịhọrọ atụmatụ ọgwụgwọ ziri ezi

Nke kacha mma ọgwụgwọ ọrịa cancer akpa ume neuroendocrine Atụmatụ bụ nke ukwuu n'otu n'otu na dabere na ihe dị iche iche, gụnyere ụdị na ogbo nke cancer, n'ozuzu ahụike onye ọrịa, na mmasị onwe onye. Mmekọrịta dị nso na onye ọkachamara n'ihe gbasara oncologist dị mkpa maka ịmepụta usoro ọgwụgwọ ahaziri iche. Na Shandong Baofa Cancer Research Institute, anyị na-agba mbọ inye nlekọta zuru oke na ọmịiko maka ndị ọrịa anyị niile.

Prognosis na nlekọta na-esochi

Prognosis maka neuroendocrine akpa ume cancer dịgasị iche iche dabere n'ụdị na ogbo ọrịa kansa, yana ahụike zuru oke nke onye ọrịa. Oge nleba anya mgbe niile dị oke mkpa maka nyochaa ịdị irè ọgwụgwọ yana ịchọpụta nlọghachi ọ bụla. Nhọpụta ndị a na-agụnyekarị nyocha onyonyo na nyocha anụ ahụ.

Ihe ndị ọzọ

Maka ozi ndị ọzọ gbasara neuroendocrine akpa ume cancer na ọgwụgwọ ya, kpọtụrụ dọkịta gị ma ọ bụ zoo aka na isi mmalite ndị dị ka National Cancer Institute (https://www.cancer.gov/). Dozie mkparịta ụka gị na onye na-ahụ maka ahụike gị mgbe niile tupu ịme mkpebi ọ bụla gbasara ọgwụgwọ gị.